Prudential Financial Inc. Acquires 5,180 Shares of LivaNova PLC (LIVN)
Prudential Financial Inc. raised its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 21.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,552 shares of the company’s stock after buying an additional 5,180 shares during the period. Prudential Financial Inc. owned about 0.06% of LivaNova PLC worth $1,809,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Exane Derivatives lifted its position in LivaNova PLC by 814.8% during the second quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after buying an additional 2,811 shares in the last quarter. Teacher Retirement System of Texas acquired a new position in LivaNova PLC during the second quarter valued at approximately $204,000. LS Investment Advisors LLC lifted its position in LivaNova PLC by 14.5% during the second quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock valued at $211,000 after buying an additional 436 shares in the last quarter. Bessemer Group Inc. acquired a new position in LivaNova PLC during the second quarter valued at approximately $220,000. Finally, Eqis Capital Management Inc. acquired a new position in LivaNova PLC during the second quarter valued at approximately $335,000. 82.26% of the stock is currently owned by hedge funds and other institutional investors.
In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $61.55, for a total transaction of $61,550.00. Following the completion of the sale, the director now owns 56,437 shares of the company’s stock, valued at $3,473,697.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 3,000 shares of company stock valued at $190,860 in the last ninety days. Company insiders own 0.28% of the company’s stock.
Shares of LivaNova PLC (NASDAQ LIVN) opened at 70.06 on Friday. The stock’s 50 day moving average is $62.98 and its 200-day moving average is $57.94. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $70.50. The stock has a market cap of $3.42 billion, a price-to-earnings ratio of 125.11 and a beta of 0.58.
LivaNova PLC (NASDAQ:LIVN) last announced its earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. The firm had revenue of $321.40 million during the quarter, compared to analysts’ expectations of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The business’s revenue was up .1% compared to the same quarter last year. On average, analysts anticipate that LivaNova PLC will post $3.25 EPS for the current year.
A number of research analysts have weighed in on LIVN shares. Jefferies Group LLC lifted their price target on shares of LivaNova PLC from $76.00 to $80.00 and gave the company a “buy” rating in a research report on Friday, September 15th. Needham & Company LLC raised shares of LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research report on Friday, September 15th. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 price target on shares of LivaNova PLC in a research report on Friday, August 11th. BidaskClub cut shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $71.00 price target on shares of LivaNova PLC in a research report on Wednesday, September 20th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. LivaNova PLC has an average rating of “Hold” and a consensus price target of $71.50.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.